Genomic testing in the NICU - a game changer for newborn health

Discover how genomic testing is transforming outcomes for critically ill newborns in the NICU. In this expert-led session, the Revvity Omics lab team will discuss cutting-edge technologies and methodologies that are revolutionizing the diagnosis and treatment of critically ill newborns in the NICU.

What you’ll learn:

• Genomic Testing Workflow in the NICU – Understand the step-by-step process from sample collection to data analysis.
• Integration of Omics Technologies – Discover how combining multiple omics approaches enhances diagnostic accuracy and efficiency, offering a comprehensive view of newborn health.
• urWGS vs. rWES: Reducing the Diagnostic Odyssey – Compare ultra-rapid Whole Genome Sequencing (urWGS) and rapid Whole Exome Sequencing (rWES) in accelerating diagnoses and improving outcomes for critically ill newborns.
• Real-World Case Studies – Gain insights from successful clinical applications of genomic testing in the NICU. 

Whether you're a clinician, researcher, or healthcare leader, this on-demand webinar provides actionable insights into the future of neonatal genomic care.

This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location. The content on this page is provided for informational purposes only, not as medical advice. It is not intended to substitute the consultation, diagnosis, and/or treatment provided by a qualified licensed physician or other medical professionals.